Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 15100912

[Tuberculosis prophylaxis].

Z Müjgan Güler·A Berna Dursun
View original source ↗Export metadata ↓

Abstract

Besides definition and treatment of index cases, prophylaxis plays an important role in battling tuberculosis that is still health problem in developing countries. But, in clinical practice, there are differences about prophylaxis between countries and even in our country. Approaches to prophylaxis of developed countries and current situation of our country were looked over for this purpose.

Explore related subjects

Antitubercular AgentsChemopreventionDeveloping CountriesHIV InfectionsHumansMedically Underserved AreaTuberculin TestTuberculosisEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Z Müjgan Güler, A Berna Dursun. 2003. [Tuberculosis prophylaxis].. https://pubmed.ncbi.nlm.nih.gov/15100912/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations.

3H-1,3,4-Oxadiazole-2-thione and 3H-1,3,4-oxadiazol-2-one derivatives were synthesized and tested for their in vitro antimycobacterial activity. Oxadiazolone derivatives showed an interesting antimycobacterial activity against the tested strain of Mycobacterium tuberculosis H(37)Rv, whereas the corresponding thione derivatives were devoid of activity. Molecular modeling investigations showed that the active compounds may interact at the active site of the mycobacterial cytochrome P450-dependent sterol 14alpha-demethylase in the sterol biosynthesis pathway and that their binding free energy values are in agreement with their MIC values.

Antitubercular Agents↗
PubMed2005

In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: part 14.

As a part of an ongoing search for new isoniazid-related isonicotinoylhydrazones (ISNEs), 2'-monosubstituted isonicotinohydrazides and cyanoboranes, some analogues belonging to these three series of compounds were further evaluated in an in vitro advanced antimycobacterial screening. The results here reported allowed us to extend their structure-activity relationships. A general correlation emerged between their lipophilicity and effectiveness against intracellular M. tuberculosis. On the whole, the most interesting result of this research was that some hydrazides and ISNEs proved to be more effective antimycobacterial agents than parental isoniazid in a TB-infected macrophage model.

Antitubercular Agents↗